MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1517/13543784.2013.836489

Медицинская библиотека · Expert opinion on investigational drugs · 2013

Discontinued drugs for pulmonary, allergy, gastrointestinal, arthritis (2012).

Antoniu Sabina Antonela

СтатьяОбзорПеревод в очереди

Аннотация

INTRODUCTION

Various compounds are developed to interfere with pathogenic pathways involved in inflammation processes. Some of them are able to enter the clinical development for different diseases with a common pathogenic denominator such as, for example, rheumatoid arthritis and chronic obstructive pulmonary disease (COPD), based on the preclinical evidence, but not all these molecules prove to be efficacious while tested in different phases of clinical development.

AREAS COVERED: This review discusses about the drugs that were discontinued from further development for pulmonary, allergy, gastrointestinal and arthritis diseases

EXPERT OPINION: Most of the drugs discontinued during 2012 were compounds with anti-inflammatory activity which were mostly designed to treat arthritis/rheumatoid arthritis. Some of these molecules were also intended for COPD. Many of them failed the late phases of the clinical development.

Для цитирования: Antoniu Sabina Antonela. Discontinued drugs for pulmonary, allergy, gastrointestinal, arthritis (2012).. Expert opinion on investigational drugs. 2013. DOI: 10.1517/13543784.2013.836489.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.